Richard Jun
Vision Therapy · New York, NYNPI 1548373236
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 91.9% of the total across 119 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 10 manufacturers reported payments, led by Bausch & Lomb Americas Inc. at 31.1% of the total. Among vision therapy clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 119 payments — averaging $27.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bausch & Lomb Americas Inc.$1K
- Coopervision Inc.$930
- Alcon$762
- Bausch & Lomb, A Division Of Bausch Health US, LLC$343
- AbbVie$74
- Oyster Point Pharma, Inc.$37
- plus $77 from 4 others
What the payments were for
- Speaking & faculty fees$2608%
- Food & beverage$2,96892%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bausch & Lomb Americas Inc. | 30 | $1,005 |
| Coopervision Inc. | 35 | $930 |
| Alcon | 34 | $762 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 13 | $343 |
| AbbVie | 1 | $74 |
| Oyster Point Pharma, Inc. | 2 | $37 |
| Sun Pharmaceutical Industries Inc. | 1 | $32 |
| Novartis | 1 | $19 |
| Shire North American Group Inc | 1 | $16 |
| Biotissue Holdings Inc. | 1 | $9 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INFUSE$475
- Clariti Contact Lens$142
- Precision7$125
- ULTRA$105
How this compares
$3,228 in reported general payments places this provider in the 95th percentile of 22 vision therapy providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cyclosporine | 12 | $3,311 |
| Latanoprost | 13 | $277 |
| Timolol Maleate | 22 | $241 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 11 | $191 |
Paid to pharmacies, not to this prescriber.
Other vision therapy in New York
- Jennifer ColavitoNew York$3K
- Daniel HazaiNew York$3K
- Shoshana CraigNew York$1K
- Loganne MikkelsenNew York$392
- Myoung Hee HanNew York$266
- Rima BakhruNew York$156
- Audra SteinerNew York$128
- Allen CohenNew York$122
- Erica SchulmanNew York$107
- Kevin LamNew York$19
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.